We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Radiotracer Improves Differential Diagnosis of Parkinson’s Disease

By MedImaging International staff writers
Posted on 11 Mar 2020
Image: Dr. Rodrigo Teodoro and Dr. Thu Hang Lai running an automated [18F]FLUDA synthesis module (Photo courtesy of HZDR)
Image: Dr. Rodrigo Teodoro and Dr. Thu Hang Lai running an automated [18F]FLUDA synthesis module (Photo courtesy of HZDR)
A new study highlights a novel positron emission tomography (PET) radionuclide that can improve image-based differential diagnostics of Parkinson's disease (PD).

Developed at Helmholtz-Zentrum Dresden-Rossendorf (HZDR; Dresden, Germany), the metabolically stable radiotracer, called [18F]FLUDA, attaches itself to adenosine (A2B) receptors in the brain and can be detected there. Metabolism studies in mice revealed that the radiometabolite can penetrate the blood-brain barrier (BBB). It also performed well in dosimetry and radiation protection studies, carried out in cooperation with the Clinic of Nuclear Medicine at the University of Leipzig (Germany), as well as in a toxicity study.

When adenosine attaches to certain receptors, it causes the nerve cells to work more slowly, including those that are significant for PD. The areas of the brain where increased radioactivity is detected must therefore have a particularly high number of receptors, which can be imaged using super-sensitive PET imaging. The study, by an interdisciplinary team from the HZDR Institute of Radiopharmaceutical Cancer Research, won the HZDR third Innovation Contest. The researchers are now preparing for clinical studies to test whether the new substance also proves its value in everyday medical practice.

“No objective criteria for the differential diagnosis of Parkinson’s disease previously existed to detect at early stage whether a patient is sensitive to the side effects, meaning that it was also impossible to develop personalized therapies,” said lead researcher Thu Hang Lai, PhD. “The new radiopharmaceutical means a great benefit for the patients, but can also reduce the treatment costs of health insurance companies.”

18F is a fluorine radioisotope that decays by positron emission 97% of the time, and electron capture 3% of the time; both modes of decay yield stable oxygen-18 (18O). 18F is an important radioisotope as a result of both its short half-life and the emission of positrons when decaying. It is primarily synthesized into fluorodeoxyglucose (FDG) for use in PET scans.

Related Links:
Helmholtz-Zentrum Dresden-Rossendorf
University of Leipzig


New
Ultrasound Needle Guidance System
SonoSite L25
Ultra-Flat DR Detector
meX+1717SCC
Portable Color Doppler Ultrasound System
S5000
New
Half Apron
Demi

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.